Carcinoid and related tumors
Atypical carcinoid tumor
Reviewer: Deepali Jain, M.D. (see Reviewers page)
Revised: 9 January 2013, last major update September 2012
Copyright: (c) 2003-2013, PathologyOutlines.com, Inc.
● Also called moderately differentiated neuroendocrine carcinoma
● Diagnostic criteria (Rosai): resembles a carcinoid but with atypical features
● More aggressive than typical carcinoid tumors: nodal metastases in 70% vs. 5%
● 5 year survival is 49-69%
● Carcinoid tumors with increased mitotic activity (2-10 per 10 HPF), nuclear pleomorphism or foci of necrosis
Various immunostains with various tumors
Atypical carcinoid tumor of lung metastatic to adrenal gland
● More intense neuroendocrine staining than small cell carcinoma
● Also positive for pancreatic polypeptide
● FoxM1(+), p27/kip1 (high, Histopathology 2012;60:731)
● Coexpression of PAX5 with c-Met (Arch Pathol Lab Med 2010;134:1702)
● Enhancer of zeste homolog 2 (Hum Pathol 2011;42:867)
● Collapsin response mediator protein (CRMP5, Am J Surg Pathol 2008;32:1699)
Electron microscopy description
● Numerous large neurosecretory granules
● Carcinoid tumor: lacks comedo-like necrosis, has < 0.2 mitotic figures/HPF (Lung Cancer 2011;71:34)
End of Lung tumor > Carcinoid and related tumors > Atypical carcinoid tumor
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at [email protected] with any questions (click here for other contact information).